Reuters — German chemicals group BASF is considering a potential offer for Syngenta, its Swiss rival which has received a C$56 billion takeover offer from Monsanto, people familiar with the matter said on Wednesday.
BASF is speaking to investment bankers about the possibility of an offer for Syngenta, though it has made no decision and no bid may materialize, the people said, asking not to be identified because the deliberations are confidential.
Syngenta has so far spurned Monsanto’s overtures citing antitrust hurdles, though lawyers representing the two companies met last week in New York to discuss whether the regulatory obstacles can be overcome, a separate source said. A BASF bid for Syngenta would also likely face significant antitrust issues.
Read Also
Alberta crop conditions improve: report
Varied precipitation and warm temperatures were generally beneficial for crop development across Alberta during the week ended July 8, according to the latest provincial crop report released July 11.
BASF, Syngenta and Monsanto declined to comment.
BASF, the world’s largest chemicals group by sales, is also developing improved plant characteristics such as drought tolerability but relies on partners, the biggest being Monsanto, to bring finished seed products to market. Other partners of BASF’s plant biotechnology business, which does not disclose sales, include Bayer and Cargill.
BASF’s crop chemicals division, with 5.4 billion euros (C$7.6 billion) in 2014 sales, commands about 11 per cent of the global crop chemicals market, in third place after Syngenta and Bayer. Any tie-up with the Swiss group would be expected to trigger considerable antitrust related asset sales.
BASF is also a potential buyer of Syngenta’s seed business should Monsanto agree to a deal with Syngenta and then sell its seed business to allay antitrust concerns, sources have previously told Reuters.
The German group, which has oil and gas operations and makes products including coatings, catalytic converters and super absorbers for diapers, trades at about 8.4 times core earnings compared with Syngenta’s multiple of 15.9, according to StarMine data.
— Reporting for Reuters by Greg Roumeliotis in New York and Edward Taylor in Frankfurt; additional reporting for Reuters by Freya Berry in London, Ludwig Burger in Frankfurt, Mike Stone in New York and Oliver Hirt in Zurich.
